Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2017 07:00 ET | Source: MacroGenics, Inc.

MacroGenics Announces Registered Direct Offering of Common Stock

Rockville, MD, April 27, 2017 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
April 26, 2017 07:00 ET | Source: MacroGenics, Inc.

MacroGenics to Present at Two Upcoming Investor Conferences in May

Rockville, MD, April 26, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
April 25, 2017 16:30 ET | Source: MacroGenics, Inc.

MacroGenics Announces Date of First Quarter 2017 Financial Results Conference Call

ROCKVILLE, MD, April 25, 2017 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Wednesday, May 3, 2017, the Company will release its financial results for the quarter...
March 31, 2017 07:30 ET | Source: MacroGenics, Inc.

Eight Posters Based on MacroGenics-developed Molecules Featured at AACR Annual Meeting 2017

Rockville, MD, March 31, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
March 29, 2017 17:30 ET | Source: MacroGenics, Inc.

MacroGenics to Present at the Needham Healthcare Conference

Rockville, MD, March 29, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
February 28, 2017 16:01 ET | Source: MacroGenics, Inc.

MacroGenics Provides Update on Corporate Progress and 2016 Financial Results

ROCKVILLE, Md., Feb. 28, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
February 27, 2017 17:30 ET | Source: MacroGenics, Inc.

MacroGenics to Participate in Two Upcoming Investor Conferences

Rockville, MD, Feb. 27, 2017 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
February 16, 2017 16:30 ET | Source: MacroGenics, Inc.

MacroGenics Announces Date of Fourth Quarter and Full Year 2016 Financial Results Conference Call

ROCKVILLE, MD, Feb. 16, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
February 09, 2017 18:00 ET | Source: MacroGenics, Inc.

MacroGenics to Present at the Leerink Partners 6th Annual Global Healthcare Conference

ROCKVILLE, MD, Feb. 09, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
January 25, 2017 16:30 ET | Source: MacroGenics, Inc.

MacroGenics Announces Appointments to Board of Directors

Rockville, MD, Jan. 25, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...